Moderna Inc (MRNA)

NASDAQ
Currency in USD
Disclaimer
79.83
+2.13(+2.74%)
Closed
After Hours
80.00+0.17(+0.21%)
Day's Range
74.5480.25
52 wk Range
62.55217.25
Prev. Close
77.7
Open
76.58
Day's Range
74.54-80.25
52 wk Range
62.55-217.25
Volume
3,823,690
Average Volume (3m)
4,054,673
1-Year Change
-56.01%
Shares Outstanding
381,283,996
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
139.76
Upside +75.07%

People Also Watch

612.47
ADBE
+0.24%
144.81
CVX
+0.84%
185.96
SNOW
-0.92%
129.67
QCOM
+0.48%
414.27
MA
+0.11%
How do you feel today about MRNA?
Vote to see community's results!
or

Moderna Inc Company Profile

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a strategic partnership with Caris Life Sciences to advance mRNA-Based oncology therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.